Abstract:In the last few years, next-generation sequencing (NGS)5 has revolutionized the approaches by which we interrogate the genetic causes of rare single-gene disorders (1). More recently, NGS has been rapidly moving into the clinical diagnostics arena and transforming the practice of molecular diagnostics testing. Many NGS-based tests for multigene panels are available in clinical laboratories. Now, proof-of-principle studies are demonstrating the feasibility of using exome sequencing for clinical testing (2–4). Dixon-Salazar et al. used exome sequencing to interrogate a cohort of 118 probands with recessive neurodevelopmental disorders and identified disease-causing mutations in 19% of the probands. Importantly, exome sequencing uncovered mutations in 10 probands (8% of the cohort) that altered the initial clinical diagnosis and led in some cases to a change in patient management (2). Calvo et al. tested 42 infants with mitochondrial diseases with the “MitoExome” (mitochondrial DNA plus exons of approximately 1000 nuclear genes) and confirmed that 10 patients (24% of the cohort) had pathogenic mutations. In addition, these investigators identified 2 novel disease-causing genes (3). Need et al. used exome sequencing in family trios to investigate patients with a broad range of phenotypic presentations and reported a 33% diagnostic yield: 4 of 12 patients with apparently causal mutations and 2 additional potentially novel disease-causing genes (4). Although the number of patients tested thus far by whole-exome sequencing (WES) or whole-genome sequencing (WGS) is still small, the data reported in these recent studies have defined the minimal diagnostic yields of such NGS-based clinical tests at their early stage of implementation, thus demonstrating the practicality of NGS-based tests. We anticipate that the clinical utility of NGS-based tests will improve further in the next few years and that more patients will benefit from improved diagnostic accuracy and more-appropriate treatment. Conventional molecular diagnostics tests evaluate a defined …

The application of whole-exome sequencing in the early diagnosis of rare genetic diseases in children: a study from Southeastern China

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Clinical Application of Whole Exome Sequencing for Monogenic Disorders in PICU of China

Prenatal diagnosis of fetuses with ultrasound anomalies by whole-exome sequencing in Luoyang city, China

Clinical use of whole exome sequencing in children with developmental delay/intellectual disability

Trio-whole exome sequencing reveals the importance of de novo variants in children with intellectual disability and developmental delay

[Application of whole exome sequencing technology in the diagnosis of hereditary eye diseases]

Genetic and phenotypic analysis of 225 Chinese children with developmental delay and/or intellectual disability using whole-exome sequencing

Clinical application of whole-exome sequencing across clinical indications

Prenatal Trio-Based Whole Exome Sequencing in Fetuses with Abnormalities of the Skeletal System

Whole exome sequencing as a diagnostic adjunct to clinical testing in fetuses with structural abnormalities

Diagnostic Whole Exome Sequencing in Patients with Short Stature

Ultra-rare renal diseases diagnosed with whole-exome sequencing: Utility in diagnosis and management

Diagnostic application of exome sequencing in Chinese children with suspected inherited kidney diseases

New insights from trio whole-exome sequencing in the children with kidney disease: A single-center retrospective cohort study

Exome and Whole-Genome Sequencing As Clinical Tests: a Transformative Practice in Molecular Diagnostics.

Application of whole exome sequencing in carrier screening for high-risk families without probands

Trio-whole exome sequencing and preimplantation genetic diagnosis for unexplained recurrent fetal malformations.

Prenatal diagnosis of skeletal dysplasias using whole exome sequencing in China

A review of consensus statements, practice resources, standards and guidelines for clinical applications of next-generation sequencing technologies in the United States

Whole-exome sequencing as the first-tier test for patients in neonatal intensive care unit: a Chinese single-center study